Axon 3189
CAS [29553-70-6]
MF C14H9NO6MW 287.22
4-CPPC is the first potent, selective and reversible inhibitor of pro-inflammatory protein macrophage migration inhibitory factor-2 (MIF-2 or D-DT) with a Ki value of 33 μM and an IC50 value of 27 μM. 4-CPPC shows competitive binding with a 13-fold selectivity for human MIF-2 versus human MIF-1.
KEYWORDS: 4-CPPC | supplier | MIF-2 inhibitor | 4CPPC | 4 CPPC | CAS [29553-70-6] | p-Hydroxyphenyl-pyruvate (HPP) | Phenylpyruvate | MIF-2 | Inhibitor | Receptors
G Pantouris et al. Structural Plasticity in the C-Terminal Region of Macrophage Migration Inhibitory Factor-2 Is Associated with an Induced Fit Mechanism for a Selective Inhibitor. Biochemistry. 2018 Jul 3;57(26):3599-3605. |
PV Tilstam et al. A selective small-molecule inhibitor of macrophage migration inhibitory factor-2 (MIF-2), a MIF cytokine superfamily member, inhibits MIF-2 biological activity. J Biol Chem. 2019 Dec 6;294(49):18522-18531. |
4-(3-Carboxyphenyl)pyridine-2,5-dicarboxylic acid
[29553-70-6]
Axon Medchem的业务之一,是独有的Axon Ligands配体库,在世界范围内,被认为是药物研发的标准。这其中,针对850余种生物靶标(包括细胞信号、基因转录、凋亡、细胞周期调控、CNS等),Axon Medchem拥有多达2000余种小分子抑制剂或调节剂。除了配体库,Axon Medchem还是欧洲著名的CRO公司,主要针对生物活性分子和药物类似分子展开合成及协议开发工作,在过去的10年中,Axon Medchem已经发现了多种潜在药物分子,并在生物医药界享有一定的声誉。